Answers are grounded in this paper and cite their sources.
Risk of oropharyngeal cancer progression and death increases directly as a function of tobacco exposure at diagnosis and during therapy and is independent of tumor p16 status and treatment.
No takes yet. Share an insight, caveat, or question.
Gillison et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: